3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
29
INDUSTRY
16
OTHER_GOV
1
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Nasopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Breast Neoplasms
3
Neoplasms, Germ Cell and Embryonal
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Cancer
1
Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement
1
Endometrial Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Interventions
Surgical Procedures, Operative
2
Dexamethasone
2
temoporfin
1
pomalidomide
1
pembrolizumab
1
nimotuzumab
1
liposomal doxorubicin
1
ledipasvir
1
ibrutinib
1
golimumab
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Thalidomide
1
Sofosbuvir
1
Rituximab
1
Ribavirin
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Mitoxantrone
1
Mastectomy
1
Irinotecan
1
Infliximab
1
Immunotherapy, Adoptive
1
Hematologic Tests
1
Drug Therapy
1
Docetaxel
1
Diagnostic Imaging
1
Dermoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Recurrence
×
Cisplatin
×
Clear all
NCT06670911
2025-02-24
ACCESS-I
Instituto Nacional de Cancer, Brazil
Phase 2
Recruiting
44 enrolled